Chinanews, August 26. According to the latest statistics from Johns Hopkins University in the United States, as of 8:28 on the 26th Beijing time, the total number of confirmed cases of new crown worldwide exceeded 23.81 million, and the cumulative deaths exceeded 817,000. The WHO said that the spread of the global epidemic is slowing; the US Food and Drug Administration apologized for exaggerating the effect of plasma therapy; the eldest son of the Brazilian president was diagnosed with new coronary pneumonia; Russia plans to start vaccination work in September.

WHO: The spread of the epidemic slows down

　　Most notable in the Americas

　　The new crown epidemic is still spreading globally, but the latest data from the World Health Organization show that the spread of the epidemic in most regions is slowing down, and the slowing trend is the most significant in the Americas.

On August 24, local time, a chain store of children's toys in Long Island, New York, USA, took restrictive measures in response to the epidemic. At the same time, only five customers were shopping in the store. As the New York State epidemic improves, indoor commercial activities in areas such as Long Island have gradually opened up. Photo by China News Agency reporter Liao Pan

　　According to the WHO report on the outbreak on the evening of the 24th, there were more than 1.7 million new confirmed cases and 39,000 new deaths last week. As of August 23, the data for a 7-day period showed that the number of new confirmed cases of new coronary pneumonia worldwide decreased by 5% compared with the previous week, and the number of new deaths decreased by 12%.

　　The WHO pointed out that, except for Southeast Asia and the Eastern Mediterranean, the number of new cases is decreasing in all regions.

　　So far, the Americas is still the most severely affected area, accounting for half of the new cases reported last week and 62% of the deaths. However, the Americas region also showed the most significant slowdown. Compared with the previous week, the number of new cases decreased by 11%, while the number of new deaths decreased by 17%, partly due to the decrease in new cases notified by the United States and Brazil. The country is currently the most severely affected country in the world.

Director of Food and Drug Administration apologizes for exaggerating plasma therapy

　　Pelosi criticized him for being "ashamed"

　　At present, the total number of confirmed cases of the new crown in the United States has exceeded 5.77 million, with more than 178,000 deaths.

　　The U.S. Food and Drug Administration (FDA) recently announced the emergency authorization of new crown plasma therapy under pressure from President Trump. However, the data cited when the authorities announced the news were revealed to be in error, and FDA Commissioner Hahn apologized for this.

　　Trump once claimed that the use of the plasma of survivors of the new crown can reduce the death rate by 35%, describing it as an "astounding number." Hahn and other health officials repeated this statement afterwards.

Data map: US President Trump.

　　But experts immediately pointed out that this data is wrong. U.S. officials claimed that the relevant data came from a study involving 35,000 patients at Mayo Clinic, one of the largest medical groups in the United States. However, Wright, the expert in charge of the study, denied that this may be the result of the FDA’s integrated Mayo Clinic and other studies. the conclusion.

　　FDA spokesperson Miller later admitted that 35% referred to "the relative difference in mortality risk between patients receiving high-dose antibodies and low-dose antibodies at Mayo Clinic." Hahn also apologized and said, "I should make it clear that this data shows a reduction in relative risk rather than absolute risk." The Speaker of the U.S. House of Representatives, Pelosi, criticized that Hahn should be ashamed of exaggerating facts.

Brazil's eldest son diagnosed

　　Former Uzbek Prime Minister Tymoshenko receives intensive care treatment

　　There are more than 3.66 million confirmed cases in Brazil. On August 25, local time, Brazilian President Bolsonaro's eldest son and Senator Flavio Bolsonaro was diagnosed with new coronary pneumonia. Flavio’s advisory team stated that he has started taking hydroxychloroquine and azithromycin and has no symptoms of infection. He also became another family member infected with new coronary pneumonia after the Bolsonaro couple and their youngest son.

Data map: On July 25, 2020, local time, Brasilia, Brazil, Brazilian President Bolsonaro announced that he tested negative for the new crown pneumonia and rode a motorcycle.

　　According to Ukrainian media reports, Yulia Tymoshenko, former prime minister of Ukraine and chairman of the Fatherland Party, who was infected with the new crown virus, was in serious condition and began receiving intensive care treatment on the evening of the 24th local time.

　　There are still about 10 weeks before the presidential election in the United States. The campaign team of the Democratic presidential candidate Biden confirmed on the 24th that Biden and his running partner Kamala Harris will be regularly tested for the new crown virus. A Biden spokesperson said that if Biden or Harris test positive, the campaign team will inform the public.

Latin America's first locally developed vaccine launches clinical trials

　　Russia plans to start vaccination work in September

　　Many countries around the world are accelerating the pace of new crown vaccine research and development. Cuba launched the first clinical trial of the first native new crown vaccine candidate on the 24th. This is the first native new crown vaccine candidate developed and conducted clinical trials in Latin America. Researchers will inject the vaccine on 676 volunteers between the ages of 19 and 80. Vaccine, test results will be released in February 2021.

Data map: Local time August 11, 2020, Moscow, Russia, Binnopharm's new crown vaccine production laboratory. Image source: People's Vision

　　The number of new cases reported in a single day in India has ranked first in the world for the 18th consecutive day. The Director-General of the Medical Research Council of India, Bhagavad, announced on the 25th that three new coronary pneumonia vaccines are undergoing clinical trials, one vaccine is in phase 2 and 3 trials, and the other two have completed phase 1.

　　The Russian Ministry of Health stated that 40,000 volunteers will participate in the post-registration trial of the new crown vaccine, and every volunteer must be observed for half a year after receiving the new crown vaccine. Alexander Günzburg, director of the National Research Center for Epidemiology and Microbiology of Russia and Malya, revealed that the Russian Federal Health Supervision Agency will inspect the mass-produced vaccines on the market. After that, on September 15-20 Vaccination work was started between.